Skip to main content
SpringerLink
Log in

A review of drug-induced hypocalcemia

  • Review Article
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Hypocalcemia (defined as total serum calcium lower than 8.5 mg/dl or as ionized serum calcium lower than 4.7 mg/dl) is a relatively common metabolic abnormality observed in hospitalized patients. Although it is associated with certain pharmacological agents such as bisphosphonates and cisplatin, hypocalcemia may occasionally develop in the course of treatment with drugs used in everyday clinical practice, including antiepileptics, aminoglycosides, and proton pump inhibitors. Hypocalcemia associated with drug treatment can be easily missed as a consequence of coexistence of multiple factors contributing to low serum calcium levels. Drug-related hypocalcemia is usually mild and asymptomatic but may be severe as well. Effective clinical management can be handled through awareness of this adverse effect induced by certain pharmaceutical compounds on serum calcium concentrations. Herein, we review pertinent clinical information on the incidence of hypocalcemia associated with specific drug treatment and discuss the underlying pathophysiological mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Desai TK, Carlson RW, Geheb MA (1988) Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting. Am J Med 84:209–214

    Article  CAS  PubMed  Google Scholar 

  2. Reber PM, Heath HIII (1995) Hypocalcemic emergencies. Med Clin N Am 79:93–106

    CAS  PubMed  Google Scholar 

  3. Editorial (1979) Serum calcium. Lancet 1:858–859

    Google Scholar 

  4. Boden SD, Kaplan FS (1990) Calcium homeostasis. Orthop Clin N Am 21:31–42

    CAS  Google Scholar 

  5. Dickerson RN, Alexander KH, Minard G, Croce MA, Brown RO (2004) Accuracy of methods to estimate ionized and “corrected” serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. JPEN J Parenter Enteral Nutr 28:133–141

    Article  CAS  PubMed  Google Scholar 

  6. Byrnes MC, Huynh K, Helmer SD, Stevens C, Dort JM, Smith RS (2005) A comparison of corrected serum calcium levels to ionized calcium levels among critically ill surgical patients. Am J Surg 189:310–314

    Article  CAS  PubMed  Google Scholar 

  7. Carmeliet G, Van Cromphaut S, Daci E, Maes C, Bouillon R (2003) Disorders of calcium homeostasis. Best Pract Res Clin Endocrinol Metab 17:529–546

    Article  CAS  PubMed  Google Scholar 

  8. Brown AJ, Dusso A, Slatopolsky E (1999) Vitamin D. Am J Physiol 277:F157–F175

    CAS  PubMed  Google Scholar 

  9. Mundy GR, Guise TA (1999) Hormonal control of calcium homeostasis. Clin Chem 45:1347–1352

    CAS  PubMed  Google Scholar 

  10. Williams SF, Meek SE, Moraghan TJ (2005) Spurious hypocalcemia after gadodiamide administration. Mayo Clin Proc 80:1655–1657

    Article  PubMed  Google Scholar 

  11. Moore CD, Newman RC, Caridi JG (2006) Spurious hypocalcemia after gadodiamide-enhanced magnetic resonance imaging: a case report and review of the literature. Rev Urol 8:165–168

    PubMed  Google Scholar 

  12. Angelopoulos NG, Goula A, Rombopoulos G, Kaltzidou V, Katounda E, Kaltsas D, Tolis G (2006) Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Bone Miner Metab 24:138–145

    Article  PubMed  Google Scholar 

  13. Yusuf B, McPhedran P, Brewster UC (2008) Hypocalcemia in a dialysis patient treated with deferasirox for iron overload. Am J Kidney Dis 52:587–590

    Article  PubMed  Google Scholar 

  14. Elisaf M, Milionis H, Siamopoulos KC (1997) Hypomagnesemic hypokalemia and hypocalcemia: clinical and laboratory characteristics. Miner Electrolyte Metab 23:105–112

    CAS  PubMed  Google Scholar 

  15. Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23:460–464

    Article  CAS  PubMed  Google Scholar 

  16. Hoffmann K, Marten A, Lindel K, Fritz S, Jager D, Buchler MW, Schmidt J (2006) Major combined electrolyte deficiency during therapy with low-dose cisplatin, 5-fluorouracil and interferon alpha: report on several cases and review of the literature [ISRCTN62866759]. BMC Cancer 6:128

    Article  PubMed  CAS  Google Scholar 

  17. Cholst IN, Steinberg SF, Tropper PJ, Fox HE, Segre GV, Bilezikian JP (1984) The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 310:1221–1225

    CAS  PubMed  Google Scholar 

  18. Koontz SL, Friedman SA, Schwartz ML (2004) Symptomatic hypocalcemia after tocolytic therapy with magnesium sulfate and nifedipine. Am J Obstet Gynecol 190:1773–1776

    Article  CAS  PubMed  Google Scholar 

  19. Nassar AH, Salti I, Makarem NN, Usta IM (2007) Marked hypocalcemia after tocolytic magnesium sulphate therapy. Am J Perinatol 24:481–482

    Article  PubMed  Google Scholar 

  20. Elisaf M, Liamis G, Liberopoulos E, Siamopoulos KC (2001) Mechanisms of hypocalcemia in alcoholic patients. Nephron 89:459–460

    Article  CAS  PubMed  Google Scholar 

  21. Dong BJ (2005) Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism. Clin Ther 27:1725–1751

    Article  CAS  PubMed  Google Scholar 

  22. Rutledge R, Sheldon GF, Collins ML (1986) Massive transfusion. Crit Care Clin 2:791–805

    CAS  PubMed  Google Scholar 

  23. Bolan CD, Cecco SA, Wesley RA, Horne M, Yau YY, Remaley AT, Childs RW, Barrett AJ, Rehak NN, Leitman SF (2002) Controlled study of citrate effects and response to IV calcium administration during allogeneic peripheral blood progenitor cell donation. Transfusion 42:935–946

    Article  CAS  PubMed  Google Scholar 

  24. Jacobson MA, Gambertoglio JG, Aweeka FT, Causey DM, Portale AA (1991) Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. J Clin Endocrinol Metab 72:1130–1135

    Article  CAS  PubMed  Google Scholar 

  25. Dalamaga M, Karmaniolas K, Nikolaidou A, Papadavid E (2008) Hypocalcemia, hypomagnesemia, and hypokalemia following hydrofluoric acid chemical injury. J Burn Care Res 29:541–543

    Article  PubMed  Google Scholar 

  26. Greco RJ, Hartford CE, Haith LR Jr, Patton ML (1988) Hydrofluoric acid-induced hypocalcemia. J Trauma 28:1593–1596

    Article  CAS  PubMed  Google Scholar 

  27. Baxter AJ, Krenzelok EP (2008) Pediatric fatality secondary to EDTA chelation. Clin Toxicol (Phila) 46:1083–1084

    Google Scholar 

  28. Conte PF, Latreille J, Mauriac L, Calabresi F, Santos R, Campos D, Bonneterre J, Francini G, Ford JM (1996) Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group. J Clin Oncol 14:2552–2559

    CAS  PubMed  Google Scholar 

  29. Kohno N, Aogi K, Minami H, Nakamura S, Asaga T, Iino Y, Watanabe T, Goessl C, Ohashi Y, Takashima S (2005) Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial. J Clin Oncol 23:3314–3321

    Article  CAS  PubMed  Google Scholar 

  30. Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809

    Article  CAS  PubMed  Google Scholar 

  31. Champallou C, Basuyau JP, Veyret C, Chinet P, Debled M, Chevrier A, Grongnet MH, Brunelle P (2003) Hypocalcemia following pamidronate administration for bone metastases of solid tumor: three clinical case reports. J Pain Symptom Manage 25:185–190

    Article  PubMed  Google Scholar 

  32. Murray RM, Grill V, Crinis N, Ho PW, Davison J, Pitt P (2001) Hypocalcemic and normocalcemic hyperparathyroidism in patients with advanced prostatic cancer. J Clin Endocrinol Metab 86:4133–4138

    Article  CAS  PubMed  Google Scholar 

  33. Smallridge RC, Wray HL, Schaaf M (1981) Hypocalcemia with osteoblastic metastases in patient with prostate carcinoma. A cause of secondary hyperparathyroidism. Am J Med 71:184–188

    Article  CAS  PubMed  Google Scholar 

  34. Rosen CJ, Brown S (2003) Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med 348:1503–1504

    Article  PubMed  Google Scholar 

  35. Calvo MS, Whiting SJ, Barton CN (2005) Vitamin D intake: a global perspective of current status. J Nutr 135:310–316

    CAS  PubMed  Google Scholar 

  36. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338:777–783

    Article  CAS  PubMed  Google Scholar 

  37. Gloth FMIII, Tobin JD (1995) Vitamin D deficiency in older people. J Am Geriatr Soc 43:822–828

    PubMed  Google Scholar 

  38. Machado CE, Flombaum CD (1996) Safety of pamidronate in patients with renal failure and hypercalcemia. Clin Nephrol 45:175–179

    CAS  PubMed  Google Scholar 

  39. Danner SA, Carr A, Leonard JM, Lehman LM, Gudiol F, Gonzales J, Raventos A, Rubio R, Bouza E, Pintado V, Hsu A, Valdes JM, Boucher CAB, Cooper DA (1995) A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med 333:1528–1533

    Article  CAS  PubMed  Google Scholar 

  40. Hahn TJ (1980) Drug-induced disorders of vitamin D and mineral metabolism. Clin Endocrinol Metab 9:107–127

    Article  CAS  PubMed  Google Scholar 

  41. Sotaniemi EA, Hakkarainen HK, Puranen JA, Lahti RO (1972) Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy. Ann Int Med 77:389–394

    CAS  PubMed  Google Scholar 

  42. Valimaki MJ, Tiihonen M, Laitinen K, Tahtela R, Karkkainen M, Lamberg-Allardt C, Makela P, Tunninen R (1994) Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res 9:631–637

    CAS  PubMed  Google Scholar 

  43. Weinstein RS, Bryce GF, Sappington LJ, King DW, Gallagher BB (1984) Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab 58:1003–1009

    Article  CAS  PubMed  Google Scholar 

  44. Petty SJ, O’Brien TJ, Wark JD (2007) Anti-epileptic medication and bone health. Osteoporos Int 18:129–142

    Article  CAS  PubMed  Google Scholar 

  45. Kovacs CS, Jones G, Yendt ER (1994) Primary hyperparathyroidism masked by antituberculous therapy-induced vitamin D deficiency. Clin Endocrinol (Oxf) 41:831–836 discussion 837–838

    Article  CAS  Google Scholar 

  46. Fortenbery EJ, McDermott MT, Duncan WE (1990) Effect of theophylline on calcium metabolism and circulating vitamin D metabolites. J Bone Miner Res 5:321–324

    CAS  PubMed  Google Scholar 

  47. Kido Y, Okamura T, Tomikawa M, Yamamoto M, Shiraishi M, Okada Y, Kimura T, Sugimachi K (1996) Hypocalcemia associated with 5-fluorouracil and low dose leucovorin in patients with advanced colorectal or gastric carcinomas. Cancer (Phila) 78:1794–1797

    Article  CAS  Google Scholar 

  48. Ober KP, Hennessy JF, Hellman RM (1981) Severe hypocalcemia associated with chronic glutethimide addiction: a case report. Am J Psychiatry 138:1239–1240

    CAS  PubMed  Google Scholar 

  49. Rose BD (1991) Diuretics. Kidney Int 39:336–352

    Article  CAS  PubMed  Google Scholar 

  50. Haas M (1994) The Na–K–Cl cotransporters. Am J Physiol 267:C869–C885

    CAS  PubMed  Google Scholar 

  51. Milionis HJ, Alexandrides GE, Liberopoulos EN, Bairaktari ET, Goudevenos J, Elisaf MS (2002) Hypomagnesemia and concurrent acid–base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Failure 4:167–173

    Article  CAS  Google Scholar 

  52. Park DS, Vassilopoulou Sellin R, Tu S (2001) Estramustine-related hypocalcemia in patients with prostate carcinoma and osteoblastic metastases. Urology 58:105

    Article  CAS  PubMed  Google Scholar 

  53. Madison DL, Beer TM, Bliziotes MM (2002) Acute estramustine-induced hypocalcemia unmasking severe vitamin D deficiency. Am J Med 112:680–681

    Article  PubMed  Google Scholar 

  54. Locatelli F, Rossi F (2005) Incidence and pathogenesis of tumor lysis syndrome. Contrib Nephrol 147:61–68

    CAS  PubMed  Google Scholar 

  55. Ainley EJ, Winwood PJ, Begley JP (2005) Measurement of serum electrolytes and phosphate after sodium phosphate colonoscopy bowel preparation: an evaluation. Dig Dis Sci 50:1319–1323

    Article  CAS  PubMed  Google Scholar 

  56. Beloosesky Y, Grinblat J, Weiss A, Grosman B, Gafter U, Chagnac A (2003) Electrolyte disorders following oral sodium phosphate administration for bowel cleansing in elderly patients. Arch Int Med 163:803–808

    Article  Google Scholar 

  57. Woo YM, Crail S, Curry G, Geddes CC (2006) A life threatening complication after ingestion of sodium phosphate bowel preparation. BMJ 333:589–590

    Article  PubMed  Google Scholar 

  58. Kuehn D, May J, Bauer AJ (2008) Phospho-soda-induced symptomatic hypocalcemia in a patient with cystic fibrosis and vitamin D malabsorption. J Pediatr Gastroenterol Nutr 47:514–516

    Article  PubMed  Google Scholar 

  59. Niemeijer ND, Rijk MC, van Guldener C (2008) Symptomatic hypocalcemia after sodium phosphate preparation in an adult with asymptomatic hypoparathyroidism. Eur J Gastroenterol Hepatol 20:356–358

    Article  PubMed  Google Scholar 

  60. Fass R, Do S, Hixson LJ (1993) Fatal hyperphosphatemia following Fleet Phospo-Soda in a patient with colonic ileus. Am J Gastroenterol 88:929–932

    CAS  PubMed  Google Scholar 

  61. Farah R (2005) Fatal acute sodium phosphate enemas intoxication. Acta Gastroenterol Belg 68:392–393

    PubMed  Google Scholar 

  62. Azzam I, Kovalev Y, Storch S, Elias N (2004) Life threatening hyperphosphataemia after administration of sodium phosphate in preparation for colonoscopy. Postgrad Med J 80:487–488

    Article  CAS  PubMed  Google Scholar 

  63. Subbiah V, Tayek JA (2002) Tetany secondary to the use of a proton-pump inhibitor. Ann Intern Med 137:219

    PubMed  Google Scholar 

  64. Tuukkanen J, Vaananen HK (1986) Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro. Calcif Tissue Int 38:123–125

    Article  CAS  PubMed  Google Scholar 

  65. Mizunashi K, Furukawa Y, Katano K, Abe K (1993) Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans. Calcif Tissue Int 53:21–25

    Article  CAS  PubMed  Google Scholar 

  66. Francois M, Levy-Bohbot N, Caron J, Durlach V (2008) Chronic use of proton-pump inhibitors associated with giardiasis: a rare cause of hypomagnesemic hypoparathyroidism? Ann Endocrinol (Paris) 69:446–448

    CAS  Google Scholar 

  67. Kinoshita Y, Masuoka K, Miyakoshi S, Taniguchi S, Takeuchi Y (2008) Vitamin D insufficiency underlies unexpected hypocalcemia following high dose glucocorticoid therapy. Bone 42:226–228

    Article  CAS  PubMed  Google Scholar 

  68. Vardi P, Benderly A, Etzioni A, Levy J, Hochberg Z (1985) Hypocalcaemia induced by glucocorticoids in a child with hypoparathyroidism treated with 1-alpha-hydroxyvitamin D3. Eur J Pediatr 144:280–282

    Article  CAS  PubMed  Google Scholar 

  69. Lai MY, Chuang CL, Lin CC, Ng YY, Yang WC (2006) Tetany during bicarbonate loading test. Kidney Int 70:1197

    Article  PubMed  Google Scholar 

  70. Mori M, Fadul NA, Bruera E, Dalal S (2008) Hypocalcemia associated with strontium-89 administration in a patient with diffuse bone metastases from neuroendocrine carcinoma. J Pain Symptom Manage 37:923–929

    Article  PubMed  Google Scholar 

  71. Nemets B, Dwolatzky T (2006) Electroconvulsive therapy-induced symptomatic hypocalcemia in a schizophrenic patient: a case report. J ECT 22:70–71

    Article  PubMed  Google Scholar 

  72. Shambaugh GE III, Khoury N, Zonschein J, Sizemore GW (1979) Hypocalcemia accompanying agranulocytosis during propylthiouracil therapy. Ann Int Med 91:576–577

    PubMed  Google Scholar 

  73. Abbas AE, Loftis R, Lester SJ, Crawford MB, Appleton CP (2002) Generalized tetany: an unusual complication during dobutamine stress echocardiography. J Am Soc Echocardiogr 15:1414–1416

    Article  PubMed  Google Scholar 

  74. Bosso JV, Gazzara PC, Rosati M (1986) Tetany associated with nifedipine. N Engl J Med 315:584–585

    Article  CAS  PubMed  Google Scholar 

  75. Vinson DR, Burke TF, Sung HM (1999) Rapid reversal of life-threatening diltiazem-induced tetany with calcium chloride. Ann Emerg Med 34:676–678

    Article  CAS  PubMed  Google Scholar 

  76. Clusin WT (2003) Calcium and cardiac arrhythmias: DADs, EADs, and alternans. Crit Rev Clin Lab Sci 40:337–375

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, School of Medicine, University of Ioannina, 451 10, Ioannina, Greece

    George Liamis, Haralampos J. Milionis & Moses Elisaf

Authors
  1. George Liamis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haralampos J. Milionis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Moses Elisaf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haralampos J. Milionis.

About this article

Cite this article

Liamis, G., Milionis, H.J. & Elisaf, M. A review of drug-induced hypocalcemia. J Bone Miner Metab 27, 635–642 (2009). https://doi.org/10.1007/s00774-009-0119-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-009-0119-x

Keywords

Search

Navigation